Position in MRK
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$610,632
-$233,442 QoQ
Shares Held
4,752
-32.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.93%
of 13F equity value
Holder Rank
#2,532
of 3,769 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Curat Global, LLC holds $5,826,997 across 10 Drug Manufacturers - General names. MRK ranks #5 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
5,380 | $1,353,823 | |
| 2 | AMGN |
Amgen Inc
|
3,403 | $1,232,294 | |
| 3 | LLY |
ELI LILLY & Co
|
1,015 | $1,217,421 | |
| 4 | PFE |
Pfizer Inc
|
28,763 | $692,613 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
4,752 | $610,632 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,088 | $263,797 | |
| 7 | NVO |
Novo Nordisk A S
|
3,830 | $183,610 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
2,723 | $156,899 |
All Filings in MRK
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $610,632 | 4,752 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $844,074 | 7,017 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $781,766 | 7,427 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,022,854 | 12,187 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $964,722 | 12,187 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $821,573 | 9,153 | Shares | Sole | 2025-04-11 | |
| No filing history on record for this holder in this stock. | ||||||